Inhibition of tumor lactate oxidation: Consequences for the tumor microenvironment
Authors:
- Morten BuskMBMorten Busk
- Stefan WalentaSWStefan Walenta
- Wolfgang Mueller-KlieserWMWolfgang Mueller-Klieser
- Torben SteinicheTSTorben Steiniche
- Steen JakobsenSJSteen Jakobsen
- Michael Robert HorsmanMHMichael Robert Horsman
- Jens OvergaardJOJens Overgaard
- 1 June 2011
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 99 (3) , 404-411
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancerRadiotherapy and Oncology, 2010
- Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PETActa Oncologica, 2010
- Impact of exogenous lactate on survival and radioresponse of carcinoma cells in vitroInternational Journal of Radiation Biology, 2009
- Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cellsRadiotherapy and Oncology, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007Radiotherapy and Oncology, 2009
- Aerobic glycolysis in cancers: Implications for the usability of oxygen‐responsive genes and fluorodeoxyglucose‐PET as markers of tissue hypoxiaInternational Journal of Cancer, 2008
- Metabolic mapping with bioluminescence: basic and clinical relevanceBiomolecular Engineering, 2002
- On the Origin of Cancer CellsScience, 1956